Genotyping of HBV using type specific primer PCR and restriction fragment length polymorphism-PCR

Paper Details

Research Paper 01/03/2018
Views (796)
current_issue_feature_image
publication_file

Genotyping of HBV using type specific primer PCR and restriction fragment length polymorphism-PCR

Imran Riaz Malik, Sawera Nayyab, Ghulam Mujtaba, Qamar Bashir
Int. J. Biosci. 12(3), 194-200, March 2018.
Copyright Statement: Copyright 2018; The Author(s).
License: CC BY-NC 4.0

Abstract

Globally, about 2.5 billion people are infected with HBV. In Pakistan, about seven million people are infected with hepatitis B. Hepatitis B is a liver inflammation caused by viral infection and can develop into liver carcinoma if not treated. HBV is categorized into eight molecular genotypes. The main objective of this study was to evaluate the efficacy of most effective method for genotyping as well as genotype distribution in Lahore, Pakistan. 130 HBV DNA positive samples were collected from different hospitals of Lahore, DNA extracted, and was preceded for amplification using type specific primer PCR and RFLP-PCR. Genotype specific amplicons were analyzed on 1.5% agarose gel electrophoresis. Results showed that genotype D was most abundant in Punjab, as first method (TSP-PCR) showed the 90.8% samples were of genotype D and 9.2% samples having the genotype C. Second method RFLP-PCR gave 94.6% samples were genotype D and 5.3% were genotype C after digesting by two enzymes Psu1 and Sty1. According to our sampling data genotyping comparison gave results: TSP-PCR showed that male have 93.50% genotype D and 6.50% genotype C and females have 88.60% genotype D and 11.40% genotype C. Second method RFLP-PCR showed that males have 96.10% genotype D and 3.90% genotype C and females have 92.40% genotype D and 7.60% genotype C. Statically analysis of both methods gave a significant P (> 0.5). It is concluded that both methods are very effective, sensitive and reliable techniques. Genotype D was found most dominant among Punjab population.

Ali MM, Hasan F, Ahmad S, Al-Nakib W. 2010. Comparative evaluation of INNO-LiPA HBV assay, direct DNA sequencing and subtractive PCR-RFLP for genotyping of clinical HBV isolates. Journal of Virology 7(1), 111.

André F. 2000. Hepatitis B epidemiology in Asia, the middle East and Africa. Vaccine, 18, S20-S22.

Arzumanyan A, Reis HM, Feitelson MA. 2013. Pathogenic mechanisms in HBV-and HCV-associated hepatocellular carcinoma. Nature Reviews Cancer 13(2), 123-135.

Badar N, Farooq U, Ali Shafaqat, Nisar N, Abubakar M, Qureshi JA. 2012. A Molecular Approach for Genotyping of Hepatitis B Virus Using Restriction Pattern Analysis of S Amplicon in Pakistan 2, 16-23.

Dokanehiifard S, Bidmeshkipour A. 2009. Study of hepatitis b virus (hbv) genotypes in kermanshah province, west of Iran. Journal of Biological Sciences 1, 113-120.

Khan AA, Khalid-ur-Raehman, Haider Z, Shafqat F. 2002. Sero Markers of hepatitis B and C in patients with cirrhosis. Journal of the College of Physicians and Surgeons Pakistan 12(2), 105-107.

Kramvis A, Kew M, Francois G. 2005. Hepatitis B virus genotypes. Vaccine 23(19), 2409-2423.

Lindh M, Gonzalez JE, Norkrans G, Horal P. 1998. Genotyping of hepatitis B virus by restriction pattern analysis of a pre-S amplicon. Journal of virological methods 72(2), 163-174.

Lu CY, Chiang BL, Chang MH, Ni YH, Hsu HM, Twu SJ, Su, IJ, Huang KM, Lee, CY. 2004. Waning immunity to plasma‐derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination. Hepatology 40(6), 1415-1420.

Lu X, Block T. 2004. Study of the early steps of the Hepatitis B Virus life cycle. International journal of medical sciences 1(1), 21.

Luby S, SP, Pasha O, Khan J, McCormick JB. 1997. The relationship between therapeutic injections and high prevalence of hepatitis C infection in Hafizabad, Pakistan. Epidemiology and Infection 119(3), 349-356.

Mizokami M, Nakano T, Orito E, Tanaka Y, Sakugawa H, Mukaide M, Robertson BH. 1999. Hepatitis B virus genotype assignment using restriction fragment length polymorphism patterns. FEBS letter 450(1), 66-71.

Norder H, Courouce AM, Echevarria JM, Lee SD, Mushahwar IK, Roberston BH, Locamini S, Magnius LO. 2004. Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology 47(6), 289-309.

Schaefer S. 2007. Hepatitis B virus taxonomy and hepatitis B virus genotypes.World journal of gastroenterology 13(1), 14.

Umar M, Busha HT, Younis N, Bashir N. 1999. Clinical spectrum of chronic liver disease due to HBV, HCV and dual infection–a comparative study. Pakistan Journal of Gastroenterol 13(1-2), 1-3.

Yalcinkaya KT, Ucar H, Uzun M, Esen B, Shirachi R, Miyamura K, Yamamoto H. 2005. Subtypes of hepatitis B surface antigent in Turkey. Japan Journal of Infectious Disease 58, 120-122.

Zekri A-R N, Hafez MM, Mohamed N, Hassan ZK, El-Sayed MH. 2007. Hepatitis B virus (HBV) genotypes in Egyptian pediatric cancer patients with acute and chronic active HBV infection. Virology journal 4(1),74.

Zeng G-B, Wen, Shu-Juan, Wang Zhan-Hui, Yan Li, Sun J, Hou Jin-Lin. 2004. A novel hepatitis B virus genotyping system by using restriction fragment length polymorphism patterns of S gene amplicons. World Journal of Gastroenterology 10(21), 3132-3136.

Related Articles

Intra-population genetic diversity modeling of date palm (Phoenix dactylifera L.) population in Niger

Adamou Ibrahim Maman Laouali*, Zango Oumarou, Alio Moussa Abdourazak, Rafiou Abdoulaye, Idi Saidou Sani, Idi Garba Nana Mariama, Bakasso Yacoubou, Int. J. Biosci. 29(3), 62-70, September 2026.

Biocontrol potential of indigenous Trichoderma isolates against Fusarium wilt of cotton in Tanzania: In vitro screening and screen-house validation

Fauzia Khalid Mpiganzila*, Alfonce Leonard, Lidia Munuo, Ernest Mbega, Agatha Aloyce, Int. J. Biosci. 29(3), 44-61, September 2026.

In vitro study of antioxidant, anti-inflammatory and antihyperglycemic activity of medicinal plants

T. K. Nishath*, P. Mathavi, V. Ambikapathy, P. Prakash, A. Panneerselvam, Int. J. Biosci. 29(3), 32-43, September 2026.

Association between the IL13 rs1800925 (-1112C/T) polymorphism and Schistosoma mansoni infection intensity in a population from western Côte d’Ivoire

Bernardin Ahouty Ahouty*, Abla Edwige Sokouri, Georges Bohoussou Kassi, Innocent Allépo Abé, Martial Kassi N’djetchi, Yaya Ouangbo Ouattara, Ornella Karmelle Lydia Dago, Mathurin Yao Koffi, Thomas Konan Konan, Mathurin N’Goran Koffi, Int. J. Biosci. 29(3), 20-31, September 2026.

Abattoir-based surveillance reveals geographic clustering and risk factors for bovine tuberculosis in Tanzania

Yohana Siyajali Anatory*, Beatus Lyimo, Blandina T. Mmbaga, Joram Buza, Int. J. Biosci. 29(3), 11-19, September 2026.

In vitro assessment of the anticancer activity of quinaldic acid against human breast cancer cells (MCF-7)

N. Medhavi, S. M. Sivasankaran, K. Selvakumar, K. Harish, S. Manoharan*, Int. J. Biosci. 29(3), 1-10, September 2026.

In silico molecular docking analysis of quinaldic acid against cancer related targets

N. Medhavi, K. Harish, S. M. Sivasankaran, K. Selvakumar, B. Vidhyambigai, S. Manoharan*, Int. J. Biosci. 29(2), 129-139, August 2026.

First records of Macrogyrodactylus clarii and six species of Quadriacanthus (Monogenea) infecting Clarias gariepinus (Burchell, 1822) across four localities in Senegal

Arfang Diamanka*, Abdou Toure, Sikhou Drame, Cheikh Diop, Ngor Faye, Int. J. Biosci. 29(2), 118-128, August 2026.